HJIM
NVO

Henry James International Management’s Novo Nordisk NVO Stock Holding History

Henry James International Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.72M Buy
56,781
+7,625
+16% +$328K 0.82% 40
2026
Q1 		$1.81M Sell
49,156
-45
-0.1% -$2.13K 0.65% 42
2025
Q4 		$2.5M Sell
49,201
-9
-0% -$460 0.79% 38
2025
Q3 		$2.73M Hold
49,210
– – 0.84% 38
2025
Q2 		$3.4M Sell
49,210
-2,900
-6% -$197K 1.12% 29
2025
Q1 		$3.62M Sell
52,110
-39
-0.1% -$3.22K 1.24% 27
2024
Q4 		$4.49M Sell
52,149
-7
-0% -$757 1.62% 20
2024
Q3 		$6.21M Sell
52,156
-3,608
-6% -$481K 2.16% 13
2024
Q2 		$7.96M Buy
55,764
+2,021
+4% +$268K 2.82% 11
2024
Q1 		$6.9M Buy
53,743
+6,796
+14% +$809K 2.13% 13
2023
Q4 		$4.86M Buy
46,947
+3
+0% +$297 1.82% 18
2023
Q3 		$4.27M Buy
46,944
+36,980
+371% +$3.26M 1.85% 19
2023
Q2 		$806K Buy
9,964
+3,500
+54% +$286K 0.35% 56
2023
Q1 		$514K Buy
+6,464
New +$458K 0.22% 81

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
GIM
Generate Investment Management Auckland, New Zealand $2.43B AUM 37.24% 1-Year Est. Return

Henry James International Management's NVO Position: Q2 2026 in Review

Henry James International Management increased its Novo Nordisk (NVO) stake by 16% in Q2 2026, buying an estimated $328K and bringing the position to 56,781 shares worth $2.72M. The position accounts for 0.82% of the portfolio, ranked #40.

Henry James International Management first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.96M in Q2 2024. 571 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Henry James International Management held 56,781 shares of Novo Nordisk worth $2.72M as of Q2 2026.
  • Henry James International Management bought 7,625 Novo Nordisk shares in Q2 2026, an estimated $328K.
  • Novo Nordisk made up 0.82% of Henry James International Management's portfolio in Q2 2026, its #40 holding.
  • Henry James International Management first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Henry James International Management's Novo Nordisk position peaked at $7.96M in Q2 2024.
  • 571 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Henry James International Management's 13F filing for Q2 2026, filed 9 Jul 2026.